Brief: Karuna Therapeutics Says Complaint Was Filed By Karuna Stockholder Seeking To Enjoin Proposed Merger With Bristol-Myers Squibb
01/03/2024 11:18
March 1 (Reuters) - Bristol-Myers Squibb Co BMY.N :
* KARUNA THERAPEUTICS-COMPLAINT WAS FILED BY KARUNA
STOCKHOLDER
SEEKING TO ENJOIN PROPOSED MERGER WITH BRISTOL-MYERS SQUIBB
* KARUNA THERAPEUTICS INC - COMPLAINT ALLEGES THAT PROXY
STATEMENT WAS MATERIALLY INCOMPLETE AND MISLEADING
* KARUNA THERAPEUTICS - KARUNA VIGOROUSLY DENIES PROXY
STATEMENT
IS DEFICIENT IN ANY RESPECT AND THAT SUPPLEMENTAL DISCLOSURES
ARE MATERIAL OR REQUIRED
Source text for Eikon: ID:n0001140361-24-010584
Further company coverage: BMY.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Karuna Therapeutics
See all newsMoody's says pharma outlook turns 'positive' on GLP-1 drug push
Brief: Karuna Therapeutics Says Complaint Was Filed By Karuna Stockholder Seeking To Enjoin Proposed Merger With Bristol-Myers Squibb
Karuna Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Karuna Therapeutics Inc expected to post a loss of $2.65 a share - Earnings Preview
Bristol Myers posts better-than-expected 4th-quarter results (updated)